This brand name is authorized in Ecuador, Estonia, Spain, Finland, Croatia, Ireland, Israel, Japan, Malta, Mexico, Poland, United Kingdom, South Africa
The drug DALACIN contains one active pharmaceutical ingredient (API):
|
1
Clindamycin
UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE
|
|
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DALACIN CREAM Vaginal Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D10AF01 | Clindamycin | D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne |
| G01AA10 | Clindamycin | G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics |
| J01FF01 | Clindamycin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 28523-07-08 |
| Country: EE | Ravimiamet | Identifier(s): 1011160, 1023938, 1776517 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 49152, 58782, 58783, 60034, 62911 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 066707, 151852, 151860, 412064, 464891, 494542, 539973, 588574, 596031, 597401 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 138622, 142195, 26801 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 19685, 30587 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 2871, 4402 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6112001M1031, 6112001M2038 |
| Country: MT | Medicines Authority | Identifier(s): PI770/11001A, PI770/11002A |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 158M92, 484M2000 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100075041, 100350790, 100353155, 100433948, 100451834, 100465810 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 27/20.1.1/0292, 36/20.1.1/0007 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
